Search Within

Paul K Paik

Formats
  1. Meeting Abstract (168)
  2. Journal Article (85)
  3. Review (5)
  4. Book Section (1)
Groups
  1. Department of Medicine (259)
  2. Solid Tumor Oncology Division (259)
  3. Thoracic Oncology (259)
  4. GSK Faculty (77)
  5. Department of Pathology and Laboratory Medicine (73)
  6. Human Oncology and Pathogenesis Program (55)

More Groups

People
  1. Mark Kris (55)
  2. Marc Ladanyi (47)
  3. Gregory Riely (42)
  4. Natasha Rekhtman (41)
  5. Charles Rudin (40)
  6. Jamie Chaft (34)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (32)
  4. 2022 (39)
  5. 2021 (34)
  6. 2020 (18)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (49)
  3. Annals of Oncology (34)
  4. Clinical Cancer Research (13)
  5. International Journal of Radiation Oncology, Biology, Physics (11)
  6. Clinical Lung Cancer (6)

More Publications

Publishers
  1. Elsevier Inc. (82)
  2. American Society of Clinical Oncology (56)
  3. Oxford University Press (38)
  4. American Association for Cancer Research (23)
  5. Wiley Blackwell (12)
  6. Nature Publishing Group (11)

More Publishers

Results (259)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KEAPSAKE study of telaglenastat vs placebo plus standard-of-care in 1L KEAP1/NRF2-mutated non-squamous metastatic NSCLC
    Meeting Abstract

    Spigel, D. R.; Akerley, W.; Evangelist, M.; Johnson, M.; Levy, B.; Owonikoko, T.; Paik, P.; Papagiannakopoulos, T.; Reckamp, K.; Akella, L.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase II randomized trial to evaluate prednisone taper with or without nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z.; Lobaugh, S.; Zhang, Z.; Geyer, A.; Gelblum, D.; Abdulnour, R.; Shepherd, A.; Shaverdian, N.; McCune, M.; Li, H.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • METex14 ctDNA dynamics & resistance mechanisms detected in liquid biopsy (LBx) from patients (pts) with METex14 skipping NSCLC treated with tepotinib
    Meeting Abstract

    Paik, P. K.; Veillon, R.; Felip, E.; Cortot, A.; Sakai, H.; Mazieres, J.; Thomas, M.; Reinmuth, N.; Raskin, J.; Conte, P. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Intracranial activity of tepotinib in patients (pts) with MET exon 14 (METex14) skipping NSCLC enrolled in VISION
    Meeting Abstract

    Patel, J. D.; Le, X.; Veillon, R.; Anderson, I. C.; Bestvina, C. M.; Demedts, I.; Garassino, M. C.; Mazieres, J.; Morise, M.; Smit, E. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp)
    Meeting Abstract

    Le, X.; Paz-Ares, L. G.; Van Meerbeeck, J.; Viteri, S.; Galvez, C. C.; Baz, D. V.; Kim, Y. C.; Kang, J. H.; Schumacher, K. M.; Karachaliou, N.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-in-human phase I study of the bifunctional EGFR/TGF beta fusion protein BCA101 in patients with EGFR-driven advanced solid cancers
    Meeting Abstract

    Janku, F.; Hanna, G. J.; Carvajal, R. D.; Paik, P. K.; Hernando-Calvo, A.; Gillison, M. L.; Fu, S.; Wheler, J. J.; Bohr, D.; Reiners, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • US health utility in advanced non-small cell lung cancer (NSCLC) patients harboring MET exon 14 (METex14) skipping mutations treated with tepotinib
    Meeting Abstract

    Paik, P. K.; Yang, M.; Knowles, E.; Hatswell, A.; Vioix, H.; Liu, F. X.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Reinmuth, N.; Popat, S.; Paz-Ares, L.; Knowles, E.; Hatswell, A.; McLean, T.; Adrian, S.; Gaumond, B.; Vioix, H.; Paik, P. K.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Garassino, M. C. C.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E. F. F.; Mazieres, J.; Cortot, A. B.; Raskin, J.; Thomas, M.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save